UniProt ID | MSL2_HUMAN | |
---|---|---|
UniProt AC | Q9HCI7 | |
Protein Name | E3 ubiquitin-protein ligase MSL2 | |
Gene Name | MSL2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 577 | |
Subcellular Localization | ||
Protein Description | Component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at lysine 16 which is implicated in the formation of higher-order chromatin structure. Acts as an E3 ubiquitin ligase that promotes monoubiquitination of histone H2B at 'Lys-35' (H2BK34Ub), but not that of H2A. This activity is greatly enhanced by heterodimerization with MSL1. H2B ubiquitination in turn stimulates histine H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1.. | |
Protein Sequence | MNPVNATALYISASRLVLNYDPGDPKAFTEINRLLPYFRQSLSCCVCGHLLQDPIAPTNSTCQHYVCKTCKGKKMMMKPSCSWCKDYEQFEENKQLSILVNCYKKLCEYITQTTLARDIIEAVDCSSDILALLNDGSLFCEETEKPSDSSFTLCLTHSPLPSTSEPTTDPQASLSPMSESTLSIAIGSSVINGLPTYNGLSIDRFGINIPSPEHSNTIDVCNTVDIKTEDLSDSLPPVCDTVATDLCSTGIDICSFSEDIKPGDSLLLSVEEVLRSLETVSNTEVCCPNLQPNLEATVSNGPFLQLSSQSLSHNVFMSTSPALHGLSCTAATPKIAKLNRKRSRSESDSEKVQPLPISTIIRGPTLGASAPVTVKRESKISLQPIATVPNGGTTPKISKTVLLSTKSMKKSHEHGSKKSHSKTKPGILKKDKAVKEKIPSHHFMPGSPTKTVYKKPQEKKGCKCGRATQNPSVLTCRGQRCPCYSNRKACLDCICRGCQNSYMANGEKKLEAFAVPEKALEQTRLTLGINVTSIAVRNASTSTSVINVTGSPVTTFLAASTHDDKSLDEAIDMRFDC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MNPVNATALYISAS -CCCCCHHHEEEEHH | 16.40 | 23663014 | |
10 | Phosphorylation | PVNATALYISASRLV CCCHHHEEEEHHEEE | 7.14 | 23663014 | |
12 | Phosphorylation | NATALYISASRLVLN CHHHEEEEHHEEECC | 13.46 | 23663014 | |
14 | Phosphorylation | TALYISASRLVLNYD HHEEEEHHEEECCCC | 21.25 | 23663014 | |
20 | Ubiquitination | ASRLVLNYDPGDPKA HHEEECCCCCCCHHH | 21.25 | 29967540 | |
20 | Phosphorylation | ASRLVLNYDPGDPKA HHEEECCCCCCCHHH | 21.25 | 19605366 | |
26 | Ubiquitination | NYDPGDPKAFTEINR CCCCCCHHHHHHHHH | 61.95 | - | |
29 | Phosphorylation | PGDPKAFTEINRLLP CCCHHHHHHHHHHHH | 40.59 | - | |
78 | Acetylation | KGKKMMMKPSCSWCK CCCEEEECCCCHHCC | 18.84 | 26051181 | |
85 | Ubiquitination | KPSCSWCKDYEQFEE CCCCHHCCCHHHHHH | 58.02 | 29967540 | |
94 | Ubiquitination | YEQFEENKQLSILVN HHHHHHHHHHHHHHH | 56.76 | 29967540 | |
104 | Acetylation | SILVNCYKKLCEYIT HHHHHHHHHHHHHHH | 41.28 | 7692255 | |
105 | Ubiquitination | ILVNCYKKLCEYITQ HHHHHHHHHHHHHHH | 31.71 | - | |
109 | Phosphorylation | CYKKLCEYITQTTLA HHHHHHHHHHHHHHH | 14.31 | 24719451 | |
113 | Phosphorylation | LCEYITQTTLARDII HHHHHHHHHHHHHHH | 18.35 | 24719451 | |
114 | Phosphorylation | CEYITQTTLARDIIE HHHHHHHHHHHHHHH | 14.49 | - | |
137 | Phosphorylation | LALLNDGSLFCEETE HHHHCCCCCEEEECC | 22.57 | 32142685 | |
149 | Phosphorylation | ETEKPSDSSFTLCLT ECCCCCCCCEEEEEE | 31.52 | 26074081 | |
150 | Phosphorylation | TEKPSDSSFTLCLTH CCCCCCCCEEEEEEC | 27.52 | 26074081 | |
152 | Phosphorylation | KPSDSSFTLCLTHSP CCCCCCEEEEEECCC | 20.64 | 26074081 | |
156 | Phosphorylation | SSFTLCLTHSPLPST CCEEEEEECCCCCCC | 21.22 | 26074081 | |
158 | Phosphorylation | FTLCLTHSPLPSTSE EEEEEECCCCCCCCC | 23.93 | 26074081 | |
162 | Phosphorylation | LTHSPLPSTSEPTTD EECCCCCCCCCCCCC | 52.85 | 26074081 | |
163 | Phosphorylation | THSPLPSTSEPTTDP ECCCCCCCCCCCCCC | 34.86 | 26074081 | |
164 | Phosphorylation | HSPLPSTSEPTTDPQ CCCCCCCCCCCCCCC | 46.01 | 26074081 | |
211 | Phosphorylation | RFGINIPSPEHSNTI CCCCCCCCCCCCCCC | 38.84 | 30266825 | |
215 | Phosphorylation | NIPSPEHSNTIDVCN CCCCCCCCCCCEECC | 33.72 | 30266825 | |
217 | Phosphorylation | PSPEHSNTIDVCNTV CCCCCCCCCEECCCE | 22.90 | 30266825 | |
223 | Phosphorylation | NTIDVCNTVDIKTED CCCEECCCEECCHHH | 17.90 | 28450419 | |
228 | Phosphorylation | CNTVDIKTEDLSDSL CCCEECCHHHHHCCC | 34.76 | 28270605 | |
261 | Ubiquitination | CSFSEDIKPGDSLLL ECCCCCCCCCCEEEE | 56.10 | - | |
277 | Ubiquitination | VEEVLRSLETVSNTE HHHHHHHCCCCCCCE | 5.31 | 29967540 | |
301 | Ubiquitination | LEATVSNGPFLQLSS CEEEECCCCCEEEEC | 13.56 | 29967540 | |
325 | Ubiquitination | STSPALHGLSCTAAT CCCHHHHCCCCCCCC | 21.82 | 29967540 | |
335 | Ubiquitination | CTAATPKIAKLNRKR CCCCCHHHHHHHHHC | 4.26 | 30230243 | |
343 | Phosphorylation | AKLNRKRSRSESDSE HHHHHHCCCCCCCCC | 43.10 | 23401153 | |
345 | Phosphorylation | LNRKRSRSESDSEKV HHHHCCCCCCCCCCC | 42.57 | 30266825 | |
347 | Phosphorylation | RKRSRSESDSEKVQP HHCCCCCCCCCCCCC | 47.92 | 30266825 | |
349 | Phosphorylation | RSRSESDSEKVQPLP CCCCCCCCCCCCCCC | 48.90 | 30266825 | |
351 | Ubiquitination | RSESDSEKVQPLPIS CCCCCCCCCCCCCCE | 50.55 | 29967540 | |
358 | Phosphorylation | KVQPLPISTIIRGPT CCCCCCCEEEEECCC | 16.18 | 23927012 | |
359 | Phosphorylation | VQPLPISTIIRGPTL CCCCCCEEEEECCCC | 22.57 | 23927012 | |
363 | Ubiquitination | PISTIIRGPTLGASA CCEEEEECCCCCCCC | 14.77 | 29967540 | |
365 | Phosphorylation | STIIRGPTLGASAPV EEEEECCCCCCCCCE | 40.42 | 23312004 | |
369 | Phosphorylation | RGPTLGASAPVTVKR ECCCCCCCCCEEEEC | 31.16 | 25159151 | |
373 | Phosphorylation | LGASAPVTVKRESKI CCCCCCEEEECCCCC | 21.17 | 32142685 | |
375 | Ubiquitination | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | 29967540 | |
375 | Acetylation | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | 25953088 | |
375 | Sumoylation | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | 28112733 | |
375 | Sumoylation | ASAPVTVKRESKISL CCCCEEEECCCCCCE | 40.87 | - | |
376 | Ubiquitination | SAPVTVKRESKISLQ CCCEEEECCCCCCEE | 49.43 | 29967540 | |
379 | Ubiquitination | VTVKRESKISLQPIA EEEECCCCCCEEEEE | 31.40 | - | |
380 | Ubiquitination | TVKRESKISLQPIAT EEECCCCCCEEEEEE | 7.47 | 29967540 | |
387 | Phosphorylation | ISLQPIATVPNGGTT CCEEEEEECCCCCCC | 36.90 | 28122231 | |
393 | Phosphorylation | ATVPNGGTTPKISKT EECCCCCCCCCCCEE | 41.12 | 25159151 | |
394 | Phosphorylation | TVPNGGTTPKISKTV ECCCCCCCCCCCEEE | 26.34 | 25159151 | |
399 | Ubiquitination | GTTPKISKTVLLSTK CCCCCCCEEEEECCC | 46.24 | 29967540 | |
400 | Phosphorylation | TTPKISKTVLLSTKS CCCCCCEEEEECCCC | 15.03 | - | |
404 | Phosphorylation | ISKTVLLSTKSMKKS CCEEEEECCCCCHHH | 29.63 | 24719451 | |
406 | Acetylation | KTVLLSTKSMKKSHE EEEEECCCCCHHHHC | 45.22 | 25953088 | |
406 | Ubiquitination | KTVLLSTKSMKKSHE EEEEECCCCCHHHHC | 45.22 | - | |
409 | Ubiquitination | LLSTKSMKKSHEHGS EECCCCCHHHHCCCC | 59.21 | 30230243 | |
419 | Phosphorylation | HEHGSKKSHSKTKPG HCCCCCCCCCCCCCC | 36.41 | - | |
421 | Phosphorylation | HGSKKSHSKTKPGIL CCCCCCCCCCCCCCC | 49.46 | - | |
435 | Ubiquitination | LKKDKAVKEKIPSHH CCCCHHHHHHCCCCC | 59.14 | 29967540 | |
437 | Ubiquitination | KDKAVKEKIPSHHFM CCHHHHHHCCCCCCC | 54.95 | 29967540 | |
440 | Phosphorylation | AVKEKIPSHHFMPGS HHHHHCCCCCCCCCC | 32.82 | 29255136 | |
447 | Phosphorylation | SHHFMPGSPTKTVYK CCCCCCCCCCCCEEC | 24.43 | 23401153 | |
449 | Phosphorylation | HFMPGSPTKTVYKKP CCCCCCCCCCEECCC | 40.83 | 29255136 | |
450 | Ubiquitination | FMPGSPTKTVYKKPQ CCCCCCCCCEECCCC | 39.10 | 29967540 | |
453 | Phosphorylation | GSPTKTVYKKPQEKK CCCCCCEECCCCCCC | 20.65 | 17053785 | |
454 | Ubiquitination | SPTKTVYKKPQEKKG CCCCCEECCCCCCCC | 54.35 | 29967540 | |
488 | Ubiquitination | CPCYSNRKACLDCIC CCCCCCCCHHHHHHH | 47.94 | - | |
501 | Phosphorylation | ICRGCQNSYMANGEK HHHCCCCCHHCCCCH | 7.15 | 29978859 | |
502 | Phosphorylation | CRGCQNSYMANGEKK HHCCCCCHHCCCCHH | 14.06 | 29978859 | |
508 | Acetylation | SYMANGEKKLEAFAV CHHCCCCHHEEEEEC | 65.15 | 26051181 | |
508 | Ubiquitination | SYMANGEKKLEAFAV CHHCCCCHHEEEEEC | 65.15 | - | |
509 | Ubiquitination | YMANGEKKLEAFAVP HHCCCCHHEEEEECC | 47.46 | 29967540 | |
509 | Acetylation | YMANGEKKLEAFAVP HHCCCCHHEEEEECC | 47.46 | 26051181 | |
518 | Ubiquitination | EAFAVPEKALEQTRL EEEECCHHHHHHHHE | 52.80 | - | |
518 | Acetylation | EAFAVPEKALEQTRL EEEECCHHHHHHHHE | 52.80 | 25953088 | |
540 | Phosphorylation | SIAVRNASTSTSVIN EEEEEECCCCCEEEE | 26.83 | 30108239 | |
541 | Phosphorylation | IAVRNASTSTSVINV EEEEECCCCCEEEEC | 33.35 | 27251275 | |
542 | Phosphorylation | AVRNASTSTSVINVT EEEECCCCCEEEECC | 19.05 | 27251275 | |
543 | Phosphorylation | VRNASTSTSVINVTG EEECCCCCEEEECCC | 27.40 | 27251275 | |
544 | Phosphorylation | RNASTSTSVINVTGS EECCCCCEEEECCCC | 22.29 | 30108239 | |
549 | Phosphorylation | STSVINVTGSPVTTF CCEEEECCCCCCCEE | 27.70 | 28450419 | |
551 | Phosphorylation | SVINVTGSPVTTFLA EEEECCCCCCCEEEE | 13.56 | 28450419 | |
554 | Phosphorylation | NVTGSPVTTFLAAST ECCCCCCCEEEECCC | 18.40 | 28450419 | |
555 | Phosphorylation | VTGSPVTTFLAASTH CCCCCCCEEEECCCC | 19.52 | 28450419 | |
560 | Phosphorylation | VTTFLAASTHDDKSL CCEEEECCCCCCCCH | 22.22 | 22199227 | |
561 | Phosphorylation | TTFLAASTHDDKSLD CEEEECCCCCCCCHH | 25.29 | - | |
566 | Phosphorylation | ASTHDDKSLDEAIDM CCCCCCCCHHHHHHH | 48.31 | 25849741 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MSL2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MSL2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MSL2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
P53_HUMAN | TP53 | physical | 19033443 | |
H2A2C_HUMAN | HIST2H2AC | physical | 21726816 | |
H2A2A_HUMAN | HIST2H2AA3 | physical | 21726816 | |
H2B2E_HUMAN | HIST2H2BE | physical | 21726816 | |
H32_HUMAN | HIST2H3C | physical | 21726816 | |
UB2D3_HUMAN | UBE2D3 | physical | 21726816 | |
TRIM8_HUMAN | TRIM8 | physical | 22493164 | |
H2B2E_HUMAN | HIST2H2BE | physical | 24837678 | |
UB2D3_HUMAN | UBE2D3 | physical | 24837678 | |
BRE1A_HUMAN | RNF20 | physical | 24837678 | |
BRE1B_HUMAN | RNF40 | physical | 24837678 | |
PAF1_HUMAN | PAF1 | physical | 24837678 | |
CDK9_HUMAN | CDK9 | physical | 24837678 | |
MSL1_HUMAN | MSL1 | physical | 28514442 | |
KAT8_HUMAN | KAT8 | physical | 28514442 | |
MS3L1_HUMAN | MSL3 | physical | 28514442 | |
HBB_HUMAN | HBB | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-453, AND MASSSPECTROMETRY. |